chrisvoncsefalvay/vaers-outcomes huggingface dataset:
ARTHRITIS FLARE UP JOINTS SEVERELY BURNING AND PAINFUL; DEPRESSING  FEELING; SEVERE VERTIGO; UNCONTROLLABLE ITCHING IN TORSO; DIARRHEA; NON-PRODUCTIVE DRY COUGH; INDIGESTION; PRESSURE IN HER HEAD; RINGING AND BUZZING IN HER EARS; FEELS VERY SICK; SEVERE FATIGUE; HEADACHE; NAUSEA; This spontaneous report received from a patient concerned a 75 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included arthritis (but has been under control for years), some vertigo (years ago, but has been under control for years also), pollen allergy, and pet dander allergy.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805029, and batch number: 1805029 expiry: UNKNOWN) dose was not reported, administered on 25-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 26-MAR-2021, the subject experienced arthritis flare up joints severely burning and painful. On 26-MAR-2021, the subject experienced depressing feeling. On 26-MAR-2021, the subject experienced severe vertigo. On 26-MAR-2021, the subject experienced uncontrollable itching in torso. On 26-MAR-2021, the subject experienced diarrhea. On 26-MAR-2021, the subject experienced non-productive dry cough. On 26-MAR-2021, the subject experienced indigestion. On 26-MAR-2021, the subject experienced pressure in her head. On 26-MAR-2021, the subject experienced ringing and buzzing in her ears. On 26-MAR-2021, the subject experienced feels very sick. On 26-MAR-2021, the subject experienced severe fatigue. On 26-MAR-2021, the subject experienced headache. On 26-MAR-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from diarrhea on 30-MAR-2021, and headache on 02-APR-2021, and had not recovered from severe vertigo, uncontrollable itching in torso, arthritis flare up joints severely burning and painful, non-productive dry cough, severe fatigue, depressing feeling, indigestion, ringing and buzzing in her ears, pressure in her head, nausea, and feels very sick. This report was non-serious.; Sender's Comments: V0: Medical assessment comment is not required as per standard procedure as case assessed as non-serious.
Patient reported redness and swelling of the arm radiating from shoulder to elbow. Patient did hot and cold compress and kept her arms elevated. She stated her arm is now fine with no current adverse problem.
Moderate pain and soreness at injection site and entire shoulder and neck area for 3 days.; soreness at injection site and entire shoulder and neck area for 3 days.; soreness at injection site and entire shoulder and neck area for 3 days.; soreness at injection site and entire shoulder and neck area for 3 days.; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 67-year-old non pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot number: ER9581), via an unspecified route of administration in the right arm on 22Feb2021 at 04:15 PM (at the age of 67-years-old) as dose 1, single for COVID-19 immunisation at other facility. Medical history includes diabetes, coronary artery disease and previous breast cancer; all were from an unknown date and unknown if ongoing. The patient was allergic to latex and codeine products. Concomitant medications included carvedilol; rosuvastatin; metformin and clopidogrel; all were taken for an unspecified indication, start and stop date were not reported and received within 2 weeks of vaccination. The patient previously took codeine and experienced drug hypersensitivity. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 22Feb2021 at 04:45 PM, the patient experienced moderate pain and soreness at injection site and entire shoulder and neck area for 3 days. No therapeutic measures were taken as a result of reported events. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Outcome of the events was recovering.  Follow-up attempts completed. No further information expected.
Moderna COVID- 19 Vaccine EUA 04/09/2021 2300hrs: chills, fatigue, muscle & body aches, headache, dizziness (did not alleviate at all- current time 04/10/2021 0300hrs... all symptoms started within minutes of each other)
Pain persisting for 3 weeks after injection. There is an injection site nodule on exam. Treatment - warm compress, ibuprofen PRN.
Local erythema 3x3cm around DTaP site 3 days after injection with 3.5x .5 cm hive like lesions medial to this occurring 4 days after injection. Left thigh erythema with swelling at Hep A and Hep B/ Hib site.
first 3 days after injection she hovered around 98.8 fever. accompanied with chills, intense muscles pain all over, and it moved around. like sometimes she felt like an elephant on her lap., lower backpain , head pain, itching all over on and off. rash on her left arm and all along the inside of her arm all the way down for two days and on third left side of head. Day 3 pain with chewing, numbness on the left side inside the mouth with swallowing, combination of numbness and pain on left cheek. pain on the left side of face, neck cheek and chaw line. the neck was numb to touch and didn't feel cold or hot on left side. popping in her ear and inside mouth like pop rocks. and lots of throbbing in the TMJ joint. I could touch it and i could feel the throbbing in my finger. lasted until day 8 and then resolved slowly a little bit each day.  was diagnosed with modified bells paulsey.  with sensory involvement and didn't treat with steroids. and able to swallow but it felt numb.  FaceTime with the INT to gather this info
On January 8, 2009, patient recieved intranasal life attunated influenza vaccine.  In about 3 days, he started having flu symptoms including fever, body aches and cough that lasted more than 7 days resulting in loss of work.
12:20 spouse woke PT up because she was gargling.  Passed out twice when trying to walk.
Patient received second dose of MODERNA COVID vaccination on 1/25/21 On the morning of 1/26/21 she woke up with body aches and a temperature of 100.1  Supportive measures (rest, nutrition, hydration) encouraged Will call back to be seen by provider if symptoms worsen
On 08/24/2022, my throat was filling with phlegm which was the strongest symptom , I had a fever and was tired. There was some coughing. It was not a forced cough. Some headache symptoms. Low energy. When I had the fever, the temperature was about 99.2 and my eyes were dry and uncomfortable. The fever lasted about half a day. The phlegm lasted till until I took some antiviral on 8/24/22.  That afternoon, I went to Urgent care and got the medication - Molnupiravir.
vaccinee who was nonreponder to 3 doses of Recombivax received 1st dose of Engerix B found to be non responder
My Mother became weak and achey she got very confused and forgot her medication.  Within 10 days she was taken to the er. In turn she was taken back to the er on October 22nd.  She had a bloodsugar of over 500. She could barely walk or talk. She was hospitalized in critical condition.  This was all in result of the influenza vaccine, unspecified formula. My mother was diagnosed with heart failure and passed away 3 months to the date of the vaccine.
Patient should have received adult dose (purple cap for ages 12+) but received child?s dose (orange cap for 5-11). No reactions have been reported at this time.
On 09/15/2000, 3 days post vaccination, the patient's mother reported that the patient had developed a mild case of "chicken pox" outbreak to her neck, face and diaper area and a fever of 102.5F. It was noted that this was a "greater than mild case of chicken pox". Medical attention was sought. Subsequently, the patient recovered. No further information was available.
chills; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (005570). The reporter is the patient.  A 71 year-old patient received bnt162b2 (BNT162B2), administration date 16Mar2021 (Batch/Lot number: unknown) at the age of 71 years as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CHILLS (non-serious) with onset 16Mar2021, outcome "recovering", described as "chills".  Additional information: The patient called to check on the status of the order for Chantix. While on the call, the patient stated that they were out today and was all good. Patient got the chills and was feeling a little better today (as reported) and they were sure it's going to all clear up. The patient was experiencing exactly the side effects that they said they would get.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
patient stated he was 11 when he is really 13. RN gave him a pediatric 0.2 mL dose when he should have received a 0.3 mL adult dose instead.
Patients were administered the vaccine that undergone 2 temperature excursions; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patients were administered the vaccine that undergone 2 temperature excursions) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patients were administered the vaccine that undergone 2 temperature excursions). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patients were administered the vaccine that undergone 2 temperature excursions) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment details were reported.   Most recent FOLLOW-UP information incorporated above includes: On 31-Aug-2021: Follow up report contain No New Information
Information regarding PREVNAR 13 was received from a healthcare professional regarding a 3-year-old male patient who experienced generalized urticarial rash. At 3 years of age, the patient received a "catch-up" dose on 09-Aug-2010. The patient experienced generalized urticarial rash on 10-Aug-2010. On 13-Aug-2010 the child was seen in the physician's office and the rash was still present. Treatment was unknown. No additional information was available at the time of this report.
PT EXP PAIN AND STINGING AT SOI. TREATMENT:  PT COUNSELING.  DOSE #2 9Jul90 PT EXP PAIN AT SOI SIMILARLY.
This is a spontaneous report from a contactable consumer (patient). A 56-years old female patient received BNT162B2 (COMIRNATY, Formulation: Solution for injection, Batch/Lot number was unknown) via unspecified route of administration in right arm as dose 2, single on 29Mar2021 for covid-19 immunization. The patient age at vaccination was 59 years. The patient medical history included ulcerative colitis. The patient has Covid prior vaccination. The patient concomitant medications included lyaldia and levothyroxine. The Historical vaccination included BNT162B2 (COMIRNATY, Formulation: Solution for injection, Batch/Lot number was unknown) in left arm as dose 1, single on 29Mar2021 for covid-19 immunization, the patient experienced Very sharp pains in right hip joint and abdomen on her Dose 1. On 23Apr2021, The patient experienced Right thumb muscle/joint was so sore that I couldn't Grip using my thumb and on 29Mar2021, the patient administered dose 1 on 29Mar2021 and dose 2 on 29Mar2021. The Patient was not received the treatment. The outcome of events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
17 days post vax, pt was very lethargic and slept all day. He acted as if he were drugged and he could not keep his eyes open. Child was taken to doctor that afternoon. The examination came back fine; that evening he ran a fever of 101.7 and has ran a fever everyday between 101-102.
12/21/08-chills; 12/22/08-spots across chest and back of neck; 12/23/08-low grade fever, itching, aching; rash over face, head, chest
arm discomfort, difficulty lifting her arm because of the pain; redness around the injection site; prolonged arm pain at injection site post administration; Initial information received on 17-Oct-2023 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a 64 years old female patient who experienced arm discomfort, difficulty lifting her arm because of the pain, redness around the injection site and prolonged arm pain at injection site post administration after receiving vaccine Influenza Quadrival A-B Vaccine [Fluzone QIV].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On 03-Oct-2023, the patient received 0.5 ml dose (frequency: once; strength: standard) of suspect Influenza Quadrival A-B vaccine Suspension for injection of lot UT8076NA and expiry: Jun-2024 via intramuscular route in the right deltoid for immunization.  On an unknown date, the patient developed arm discomfort, difficulty lifting her arm because of the pain (limb discomfort), redness around the injection site (vaccination site erythema) and prolonged arm pain at injection site post administration (vaccination site pain) (unknown latency) following the administration of Influenza Quadrival A-B vaccine.  No lab data was reported.  Action taken was not applicable.  It was not reported if the patient received a corrective treatment for all events.  At time of reporting, the outcome was Not Recovered / Not Resolved for all events.
Aching and soreness and swelling immediately - continued swelling and redness that traveled down arm to wrist. Symptoms lasted a week. Took acetaminophen.
Vaccination hurt more than is usual. I was told to expect my arm to hurt, which it did, especially when lifting it. However, the pain never went away, and in fact has gotten much worse. It is now Dec. 13, and I cannot lift my arm to put on clothes or put my seatbelt on because of excruciating pain in my upper arm. I researched online and found that many people are experiencing the exact same thing.
5 minutes after injection patient started to feel warm and stated that her eyes were itching. When she stood up she then started to feel dizzy. Took her to urgent care room and V/S were  134/69, 74, 98.0, 18. O2 SAT WAS 95%. Patient then stated that her lips were itchy and felt swollen. She also stated she was not having any trouble breathing. Provider ordered 50mg of Benedryl given PO to be administered. Patient stated 10 minutes later that her eyes no longer felt itchy and she wasn't warm or dizzy anymore. Continued to watch patient for 40 more minutes and when no signs or symptoms were present, provider cleared patient to leave facility
unconscious at times; perspiring profusely; bad cough; coughing until he throws up; He was very ill; high fever" of 104; really bad pain in his arm; delirious and out of it; This is a spontaneous report from a contactable nurse (patient's wife). A 63-year-old male patient received his first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm on 08Apr2021 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. Medical history included sick from Dec2019, down to the eye, diarrhea and fever. There were no concomitant medications.  The patient experienced high fever" of 104, had really bad pain in his arm, was delirious and out of it and he was very ill on 08Apr2021. The reporter also stated that the patient also was unconscious at times, perspiring profusely, had bad cough, was coughing until he throws up on an unspecified date. The event pyrexia was assessed as life-threatening and pain in arm was assessed as disability by the reporter. The patient underwent lab tests and procedures which included fever: 104 on 08Apr2021. Therapeutic measures were taken as a result of pyrexia included Tylenol. Outcome of the events was unknown.   Information on about lot/batch number has been requested.; Sender's Comments: The information currently provided is very limited, hence the reported events are conservatively assessed as related to the administration of the vaccine. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.
Heart was in A-fib, blood clot formed and had a Left Posterior Parietal Stroke
heart problem; Sunday night I was in the hospital because I have a heart problem, since then I have been feeling dizzy; This is a spontaneous report from contactable consumers (patient and his wife). A male patient of an unspecified age received the second dose of bnt162b2 (BNT162B2, Solution for injection), via an unspecified route of administration on Apr2021 (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously received the first dose of bnt162b2 (BNT162B2), on an unspecified date for COVID-19 immunisation. The patient took the second COVID Vaccine the Pfizer about 12 days prior to this report (in Apr2021). But, Sunday night (unspecified date in Apr2021) he was in the hospital (further clarification unknown) because he had a heart problem. The patient stated he never had a heart problem before. And since then, he has been feeling dizzy. He said he does not know if that was caused by the vaccine or not. Outcome of the events was unknown.   Information on lot number/batch number has been requested.
Pt received shot in morning, took nap, and woke a few hours later. Patient's daughter called in asked about adverse reactions and the patient not being able to see well. Patient's daughter was instructed it may be a reaction to the shot, although rare, and to seek medical care at urgent care if symptoms continue. This pharmacist has been notified that the patient had body aches the next morning that precipitated a visit to ER where it was thought that the high dose flu shot was responsible and the er staff recommend patient no longer receive high dose flu shots.
Patient came for their 2nd shot 2 weeks earlier than their scheduled and received the shot on 1/3/2022. Error was discovered  right after patient received shot. Supportive care involving thermometer, Tylenol 500mg and Benadryl 25mg  were provided to patients for side effects and consultation for proper care for side effects. Called was made to patient on the same evening on 1/3/2022, the next morning and on 1/5/2022 to follow up on patient condition. Patient stated that they feel fine, no fever, no headache and other complications except sore arm at that time. However, patient came to pharmacy today and reported that they have sweating, no energy and feel tired and week in the past week.
Pt rec'd inject in lt arm of DTP .5ml immediately p/inj pt's lt arm started to jerk & go into spasms;
Pt recv vax on 10/13/98; post vax pt exp increased cough, tight chest, red/puffy eyes & difficulty breathing
Information has been received from a pharmacist concerning an unspecified patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions and concomitant therapies were not informed. On an unknown date, the patient was vaccinated with ZOSTAVAX) (lot #, expiration date, dosage and therapy route were not provided), for prophylaxis. On an unspecified date, the patient developed chickenpox. The outcome of chickenpox was unknown at the time of the report. The causal relationship between chickenpox and ZOSTAVAX was not reported. No product quality complaint (PQC) was involved. Additional information has been requested.
extreme chills, body and bone ache, vomiting, headache, extreme fatigue, facial tingling, breathing difficulty, shortness of breath, fever
immobility in their arm; severe pain after receiving Adacel injection; Initial information received on 12-Oct-2022 regarding an unsolicited valid  non-serious case received from a consumer/non-hcp.  This case involves an unknown age and unknown gender (3 out of 4) patients who experienced severe pain after receiving adacel injection and immobility in their arm after receiving diphtheria-2/tetanus/5 AC pertussis vaccine [Adacel].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a  dose of suspect diphtheria-2/tetanus/5 AC pertussis vaccine, suspension for injection (lot 2CA18C; Expiry date: 29-Nov-2024) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date the patient developed immobility in their arm and severe pain after receiving Adacel injection (vaccination site pain) (vaccination site movement impairment) (unknown latency).  Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the events.  At time of reporting, the outcome was Unknown for both the events.
Review of Systems -  Review of Systems  Constitutional: Positive for fatigue and fever.  HENT: Positive for congestion and rhinorrhea.   Respiratory: Positive for cough.
"Moderna COVID-19 Vaccine EUA"  Before the adverse event, I was experiencing chills, fatigue, nausea, and a small fever. I then fell asleep. I woke up at 1:30am to brush my teeth but I couldn't take full breaths. When I was trying to take full breaths, I could only get ~70% of an inhale. This lasted for about 10 minutes. I then experienced the rest of the symptoms, minus vomitting for the rest of the day.
Information has been received from a physician concerning a 26 year old female who was vaccinated on an unspecified date with her first dose of GARDASIL (lot# not reported).  Subsequently the patient experienced urticaria 34 hours after administration of the vaccine.  Subsequently, the patient recovered from urticaria within 1 day after receiving 1 dose of loratadine (CLARITIN).  The patient sought medical attention via the telephone.  Additional information has been requested.
within 36 hours of second dose patient developed fasciculations of the right lower eyelid, which have persisted ever since
patient fainted after getting out of vaccination room and hit his head on the floor. He was laid down on the floor with his feet raised up by a chair, pt regained consciousness after a couple seconds and responded to questions. his blood pressure was 115/61. 911 was called and paramedics get to him about 5 min after. patient was monitored for blood pressure, heart rate and O2 sat then released to family
Patient was given a pediatric dose of Pfizer Covid-19 for shot #3 and not an adult dose.
3-4 minutes post flu vaccination, patient fainted. Nurse positioned patient to the floor, offered water, took vitals and monitored for 1 hour. Patient reported feeling better after 1 hour and decided to go home. Nurse advised patient to contact MD or go to ED if symptoms occur.
Pt c/o tingling sensation in hands and feet approx 10 min after vaccination. pt proceeded to faint after sensation occurred.
Moderna vial was placed in fridge on 01/01/22. Moderna vial with the lot number of, 041J21A has not undergone a temperature excursion. Patient was administered Moderna booster(0.25ML) on 02/17/22 at 3:00AM. Patient has not reported to Clinic with symptoms at this time.